2019

November 12 Issue

• Drug Pricing Update: House Vote Delayed Again
• BioNJ Submits Comments on IRS Section 382 Proposal
• Trump Nominates Stephen Hahn to Lead FDA
• Election Update

October 30 Issue

• Drug Pricing Update
• BioNJ Submits Comments on Bioeconomy RFI
• Assemblymen Schaer and Calabrese Visit BioNJ Member Cancer Genetics
• Treasury Releases $114 Million of Held Funding

October 24 – Alert

• HR 3 — We Need Your Help — Take Action Today

October 17 Issue

• Drug Pricing Update
• President Trump Unveils Medicare Executive Order
• Governor Murphy Holds Economic Development Roundtable
• NJ First Lady Murphy, NJEDA Host Golden Seeds Session
• NJCSIT Announces Return of SBIR/STTR Assistance

October 2 Issue

• Speaker Pelosi Unveils Drug Pricing Proposal, Committee Consideration Begins
• Ways and Means Releases International Drug Pricing Report
• Senate Committee Analyzing Incentives Continues Work

September 19 – Alert

•  Speaker Pelosi Releases Drug Pricing Plan

September 18 Issue

• NJ Senate Meets, Senate Committee Continues Incentive Hearings
• Congresswoman Mikie Sherill Visits Modern Meadow
• Congress Returns, Drug Pricing Discussion Continues
• White House Office Seeks Input on “Bioeconomy”

September 5 Issue

• Tax Incentive Extension Vetoed, Discussion Ongoing
• Gag Clause, Claw Back Bill Signed into Law
• Florida Submits Reimportation Proposal

August 21 Issue

• Governor Murphy Signed Innovation District Legislation
• Importation Pathways Unveiled
• CMS Finalizes CAR-T Coverage
• GAO Report: Rebates Mostly Passed to Plans

August 7 Issue

• BioNJ Unveils Value of Medical Innovation Primer
• Senate Select Committee Holds First Hearing
• Finance Committee Considers Drug Pricing Legislation
• President, Congressional Leadership Cut Budget Deal, Head Home for August District Work Period

July 10 Issue

• Governor Murphy Approves State Health Exchange
• Judge Blocks HHS DTC Rule
• CMS Approves Louisiana State Plan Amendment

July 1 – Alert

• Special 2020 Budget Edition

June 27 – Alert

•  Angel Investor Tax Credit Improvements Head to Governor’s Desk

June 26 Issue

• Washington Supplemental Rebate Amendment Approved

• President Trump Releases Transparency Executive Order

• Congress Continues Health Costs Discussion

June 12 Issue

• NJEDA Rebrands Tech Center

May 29 Issue

• HELP Committee Unveils Cost Containment Draft

• Trump Administration Scales Back on Part D Step Therapy Proposal

May 15 Issue

• Trump Administration Finalizes DTC Rule

• FDA Finalizes Guidance on Interchangeable Biologics

• Final Prescriber Ban Amendments Unveiled

• Congress Continues Drug Pricing Efforts

May 6, 2019

• CBO Analysis: Medicare for All Would Increase Costs “Substantially”

• CMS Invites States to Develop Innovative Care Models for Dual Eligibles

• Trustees Release Medicare Trust Fund Reports

• Governor Murphy Announces Grant Opportunity

April 17, 2019

• New Jersey Human Services Removes MAT Prior Authorization

• Legislative Budget Hearings Continue

• PBMs Under Senate Finance Microscope

• E&C Consider, Pass Health Care Proposals

April 3, 2019

• Governor Murphy Announces Transition to State Marketplace

• Governor Murphy Announces Higher Education Plan, BioNJ’s Hart Named to Task Force

• Trump Administration Backs Full ACA Repeal in Brief

• BioNJ Comments on Safe Harbor Proposed Regulation

March 26, 2019

• Gov. Murphy Announces Higher Ed Plan; Hart Named Working Group Co-chair

• Governor Murphy Speaks on Opportunity Zones

March 20, 2019

• State Budget Hearings Scheduled

• Safe Harbor Comments Due April 8

• PBM Hearing Scheduled for April 3

• President Trump Unveils FY20 Budget Proposal

March 6, 2019

• Joint Committee Continues Incentive Hearings

• CMS Actuary Release Health Expenditure Projections

• Senate Finance Continues Industry Investigation

• New Jersey Governor Murphy Delivers Budget Address

February 20, 2019

• New Jersey Medicaid Program Creates Innovation Office

• The Most Important New Woman in Congress Is Not Who You Think

February 6, 2019

• Incentive Task Force Formed, Legislative Hearings Coming

• Trump Administration Keeps Up Pace on Life Sciences Regulations